The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.
Launched by LMU KLINIKUM · Jul 17, 2025
Trial Information
Current as of July 23, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The Patients with sufficient cognitive and communicative abilities,
- • The Patients with confirmed by the genetic report and/or the final clinical diagnosis.
- Exclusion Criteria:
- • The Patients scored more than 23 points on the falls efficacy Scale-International
- • The Patients are unable to walk at least ten metres without assistance,
- • The patient had knee, hip or back surgery in the last three months.
- • Patients suffering from polyneuropathy without a diagnosis of inflammatory autoimmune neuropathy.
About Lmu Klinikum
LMU Klinikum is a leading academic medical center affiliated with Ludwig Maximilian University in Munich, Germany. Renowned for its commitment to innovative research and high-quality patient care, LMU Klinikum plays a pivotal role in advancing medical science through clinical trials and translational research. With a multidisciplinary approach, the institution collaborates with various stakeholders, including healthcare professionals, researchers, and industry partners, to facilitate groundbreaking studies that aim to improve therapeutic outcomes and enhance understanding of complex diseases. Its state-of-the-art facilities and expert clinical teams ensure the highest standards of safety and efficacy in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bad Feilnbach, , Germany
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported